Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia. CAR T-cell therapy is a unique way of treating hematologic ...

Here’s news I know many readers have been anxiously awaiting: The CAR-T was a success! My 30-day and 90-day PET CTs both showed “no uptake” of the radioactive dye injected as part of the scanning ...

Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...

CAR T-cell therapy re-engineers immune cells to target and eradicate high-risk blood cancers, offering potential cures where traditional chemotherapy fails. Initially requiring inpatient care due to ...

In a move that could dramatically expand access to a revolutionary new treatment, the Food and Drug Administration (FDA) has eliminated some of the safety restrictions for CAR T-cell therapies. This ...

Collaborative research explores how breakthrough engineered therapy works, why remission lasts for some patients, and how to extend its benefits This year's recipients will be exploring chimeric ...

In vivo CAR T-cell therapies could improve access by eliminating complex logistics and reducing costs, making them more accessible to underserved populations. Traditional CAR T-cell therapies face ...

Early studies show CAR T-cell therapy could help people with severe lupus reach remission. Here’s what researchers are learning about this emerging treatment. TULSA, Okla. - Lupus affects an estimated ...